Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid vs dexmedetomidine vs nitroglycerin for bleeding control during septorhinoplasty
IRCT20190325043107N47Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epistaxis comparing Intravenous tranexamic acid, Intravenous dexmedetomidine and Intravenous nitroglycerin (3 arms). Primary endpoint: Bleeding. Started Jun 2024; status: completed.
02
Drugs
tranexamic aciddexmedetomidinenitroglycerin
03
Conditions
epistaxis
Beyond the preview
Go deeper on IRCT20190325043107N47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N47.